|
May 10
|
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
|
|
May 10
|
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
|
|
May 9
|
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
|
|
May 9
|
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
|
|
May 9
|
STERIS (STE) Q4 Earnings Match Estimates, Margins Contract
|
|
May 9
|
Charles River (CRL) Q1 Earnings & Revenues Beat, Fall Y/Y
|
|
May 9
|
Zacks.com featured highlights include ResMed, Booz Allen Hamilton and Kontoor Brands
|
|
May 8
|
Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up
|
|
May 8
|
3 GARP Stocks to Scoop up for Maximum Returns
|
|
May 8
|
Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand
|
|
May 8
|
Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
|
|
May 8
|
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
|
|
May 7
|
ResMed Announces Participation in the RBCCM Global Healthcare Conference
|
|
May 7
|
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
|
|
May 7
|
Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
|
|
Apr 4
|
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
|
|
Apr 2
|
5 Medical Product Stocks to Buy Amid Industry Challenges
|
|
Apr 1
|
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 61%
|
|
Apr 1
|
Here's Why Investors Should Buy ResMed (RMD) Stock Now
|
|
Jan 16
|
ResMed says its masks to remain on market despite FDA classification
|